← brief for 2026-08-14 · Slowing decline
Reply-Glucagon-Like Peptide-1 Receptor Agonists, Weight Loss, and Kidney and Cardiovascular Protective Effects in Systemic Lupus Erythematosus.
Key takeaways
GLP-1 drugs could reduce kidney decline in lupus patients. The study had 45 patients over 2 years.
Who did this work
Jorge A · Patel AV
Source
Article · PubMed, the drug frontier · 2026 Aug 14
https://pubmed.ncbi.nlm.nih.gov/42598740/